関連する実験動画

Updated: Sep 8, 2025

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

603

IPSS-M,IPSS-RおよびAIPSS-MDSによる予後予測の比較 日常の臨床実務における分子データの限られた利用状況

Felicitas Schulz1, Carolin Kellersmann2, Beate Betz3

  • 1Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany. FelicitasIsabel.Schulz@med.uni-duesseldorf.de.

Annals of hematology
|September 6, 2025
PubMed
まとめ

国際骨髄分裂症候群の予測スコアシステム - 分子アノテーション (IPSS- M) は,MDS患者の生存率の正確な予測を提供します. しかし,分子データが頻繁に不足しているため,国際予知スコアシステム - 改訂 (IPSS-R) が最も適用可能である.

キーワード:
IPSS についてMDS について骨髄不形成症候群予測する

さらに関連する動画

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

193
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

372

関連する概念動画

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
254